Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Mol Cancer Res. 2020 Jun 8;18(9):1278–1289. doi: 10.1158/1541-7786.MCR-20-0046

Table 1. Ingenuity canonical pathways of orthotopic allograft model MSGE.

Ingenuity Pathway Analysis results showing the top 10 significantly enriched pathways by orthotopic-specific MSGE of 4T1, 6DT1, and Mvt1. Significance of enrichment for this pathway in each the gene set is indicated by the -log(p-value) where >1.3 is significant.

4T1 −log
(p-value)
6D1 −log
(p-value)
Mvt1 −log
(p-value)
Granulocyte Adhesion and Diapedesis 9.25 Th1 and Th2 Activation Pathway 17.3 Antigen Presentation Pathway 7.19
Agranulocyte Adhesion and Diapedesis 7.16 Th1 Pathway 14.9 Allograft Rejection Signaling 5.79
Th1 and Th2 Activation Pathway 7.14 Th2 Pathway 14.2 OX40 Signaling Pathway 4
VDR/RXR Activation 6.89 iCOS-iCOSL Signaling in T Helper Cells 11.8 Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells 3.27
Th2 Pathway 6.83 Altered T Cell and B Cell Signaling in Rheumatoid Arthritis 11.5 Cdc42 Signaling 3.21
T Helper Cell Differentiation 6.2 Granulocyte Adhesion and Diapedesis 11.3 Graft-versus-Host Disease Signaling 2.97
LXR/RXR Activation 4.97 Type I Diabetes Mellitus Signaling 11 Autoimmune Thyroid Disease Signaling 2.95
Th1 Pathway 4.97 CD28 Signaling in T Helper Cells 10.9 Protein Ubiquitination Pathway 2.59
iCOS-iCOSL Signaling in T Helper Cells 4.54 T Helper Cell Differentiation 10.8 Crosstalk between Dendritic Cells and Natural Killer Cells 2.44
Nur77 Signaling in T Lymphocytes 4.09 Dendritic Cell Maturation 10.4 Systemic Lupus Erythematosus In T Cell Signaling Pathway 2.35